HomeCompareQTRHF vs MRK

QTRHF vs MRK: Dividend Comparison 2026

QTRHF yields 227.27% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 QTRHF wins by $34.1K in total portfolio value
10 years
QTRHF
QTRHF
● Live price
227.27%
Share price
$0.88
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$90.9K
Annual income
$102.44
Full QTRHF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — QTRHF vs MRK

📍 QTRHF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodQTRHFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, QTRHF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
QTRHF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

QTRHF
Annual income on $10K today (after 15% tax)
$19,318.18/yr
After 10yr DRIP, annual income (after tax)
$87.07/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $8,241.34/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of QTRHF + MRK for your $10,000?

QTRHF: 50%MRK: 50%
100% MRK50/50100% QTRHF
Portfolio after 10yr
$73.8K
Annual income
$4,950.29/yr
Blended yield
6.70%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

QTRHF
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
-1.5
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

QTRHF buys
0
MRK buys
0
No recent congressional trades found for QTRHF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricQTRHFMRK
Forward yield227.27%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%32.7%
Portfolio after 10y$90.9K$56.8K
Annual income after 10y$102.44$9,798.13
Total dividends collected$43.3K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: QTRHF vs MRK ($10,000, DRIP)

YearQTRHF PortfolioQTRHF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$22,064$11,363.64$11,206$366.19+$10.9KQTRHF
2$35,324$11,716.03$12,650$502.35+$22.7KQTRHF
3$46,562$8,765.19$14,407$694.19+$32.2KQTRHF
4$55,220$5,398.93$16,585$967.82+$38.6KQTRHF
5$62,078$2,991.99$19,342$1,363.89+$42.7KQTRHF
6$67,995$1,571.75$22,913$1,947.19+$45.1KQTRHF
7$73,559$804.47$27,662$2,823.89+$45.9KQTRHF
8$79,115$406.68$34,159$4,173.35+$45.0KQTRHF
9$84,857$204.39$43,337$6,308.80+$41.5KQTRHF
10$90,900$102.44$56,776$9,798.13+$34.1KQTRHF

QTRHF vs MRK: Complete Analysis 2026

QTRHFStock

Quarterhill Inc. operates in the intelligent transportation system and intellectual property licensing industries worldwide. Its Licensing segment includes patents relating to wireless communications, memory interface technologies, semiconductor manufacturing and packaging technologies, wired connectivity, automotive applications, computer gaming, intelligent personal assistant technologies, enhanced image processing, streaming video technologies, non-volatile Flash memory, DRAM and other memory technologies, and semiconductor analog circuitry technologies. The company's Intelligent Systems segment provides international road dynamics products and services, such as red light and speed enforcement systems, automated truck weigh stations; toll road systems and equipment; traffic management and safety systems; VectorSense, a tire sensor suite; Vehicle Information-In-Motion, a traffic intelligence system; integrated traffic control systems; permanent and portable slow speed weigh-in-motion systems; portable wheel load scales; traffic data collection products; vehicle and axle detection equipment; and automated vehicle identification services and equipment, and other hardware and software products and offerings for the intelligent transportation systems industry. This segment serves through direct salespeople, distributors, agents, contractors, and systems integrators. The company was formerly known as Wi-LAN Inc. and changed its name to Quarterhill Inc. in June 2017. Quarterhill Inc. was incorporated in 1992 and is headquartered in Toronto, Canada.

Full QTRHF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this QTRHF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

QTRHF vs SCHDQTRHF vs JEPIQTRHF vs OQTRHF vs KOQTRHF vs MAINQTRHF vs JNJQTRHF vs ABBVQTRHF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.